Drugs / Tetracycline
last change 3 days ago re-read 2 minutes ago

Tetracycline

Developed for
Helicobacter pylori infectious disease · dyspepsia · dental pulp necrosis · gastric cancer · gastritis · lymphoma · periodontitis · aphthous stomatitis
+14 more · chalazion · chronic gastritis · COVID-19 · exanthem · gastric ulcer · osteonecrosis of the jaw · pleural neoplasm · pneumothorax · trachoma · bacterial vaginosis · candidiasis · post-treatment Lyme disease syndrome · stomach disorder · vulvovaginal candidiasis
Investigated by
Shandong University · Kaohsiung Veterans General Hospital. · National Taiwan University Hospital · Peking University Care Luzhong Hospital · Kaohsiung Medical University Chung-Ho Memorial Hospital · Seoul National University Bundang Hospital
+100 more · Taierzhuang District People's Hospital · Zibo Central Hospital · Heze Municipal 3rd people's hospital · Maternity and Child Care Health Center of Dezhou · National Cancer Institute (NCI) · National Cheng-Kung University Hospital · Qilu Hospital of Shandong University · Shanghai Jiao Tong University School of Medicine · The People's Hospital of Jimo.Qingdao · The University of Texas Health Science Center, Houston · Xijing Hospital of Digestive Diseases · Yuncheng Traditional Chinese Medicine Hospital · Zhengzhou Central Hospital · Academy Military Medical Science, China · Ajou University School of Medicine · Akil Al Islam · Alliance for Clinical Trials in Oncology · American University of Beirut Medical Center · Amhara Public Health Institute · Aristotle University Of Thessaloniki · Azfar Farogh · Baylor College of Medicine · Binzhou People's Hospital · Boston University · Buddhist Tzu Chi General Hospital · Centers for Disease Control and Prevention, China · Chong Kun Dang Pharmaceutical · Dezhou Hospital Qilu Hospital of Shandong University · Emory University · European Organisation for Research and Treatment of Cancer - EORTC · Federal University of Piaui · Feicheng Municipal People's Hospital · First Affiliated Hospital of Zhejiang University · Forest Laboratories · Fudan University · General Hospital of Jinan Military Region · Green Cross Corporation · Göteborg University · HK inno.N Corporation · Isfahan University of Medical Sciences · Jining No.2 People's Hospital · Liaocheng People's Hospital · Linyi People's Hospital · M.D. Anderson Cancer Center · Mackay Memorial Hospital · Ministry of Health and Welfare, Taiwan · Nanfang Hospital, Southern Medical University · National Cancer Center, Korea · National Cancer Institute of Mexico · National Eye Institute (NEI) · Peking Union Medical College Hospital · People's Hospital of Zhengzhou University · Ping-I (William) Hsu, M.D. · Qihe County City Hospital · SK Chemicals Co., Ltd. · San Diego Veterans Healthcare System · Santa Casa de Porto Alegre · Seoul National University Hospital · Shahid Beheshti University of Medical Sciences · Shandong Electric Power Central Hospital · Shandong Province Third hospital · Shandong Provincial Hospital · Shandong University of Traditional Chinese Medicine · Shanghai East Hospital · Shanghai Zhongshan Hospital · Shiraz University of Medical Sciences · Taian City Central Hospital · Texas A&M University · The Affiliated Hospital of Qingdao University · The Carter Center · The Cleveland Clinic · The First Affiliated Hospital with Nanjing Medical University · The Forsyth Institute · The People's Hospital of Guangrao · all 106 on the full record

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) ACHROMYCIN V 1963-10-18 fda.gov
Approved US (FDA) ACHROMYCIN 1953-11-19 fda.gov

Trials 76 · started per year

today
US approved 1953
1
1
1
1
1
3
2
2
5
5
3
6
1
3
4
6
2
8
7
4
4
3
3
195219531954195519561957195819591960196119621963196419651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 02 trials
Phase 0 NCT01763437 Mar 2014 → Mar 2015 chalazion The Cleveland Clinic Withdrawn No outcome recorded
Phase 0 NCT02142543 Mar → Dec 2012 aphthous stomatitis Texas A&M University Completed No outcome recorded
Phase 11 trial
Phase 1 NCT04039126 Jun 2019 → Dec 2020 pleural neoplasm University College Hospital, Ibadan Unknown No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT07475364 May → Dec 2026 expected dental pulp necrosis University of Faisalabad Not yet recruiting No outcome recorded
Phase 25 trials
Phase 2 NCT03650036 Jun 2018 → May 2019 dental pulp necrosis Federal University of Piaui Completed No outcome recorded
Phase 2 NCT01880515 Dec 2010 → Jul 2014 exanthem, lung cancer National Cancer Institute of Mexico Completed No outcome recorded
Phase 2 NCT02057926 Nov 2009 → Nov 2011 Universitat Internacional de Catalunya Completed No outcome recorded
Phase 2 NCT00003151 Sep 1997 → Oct 1998 lymphoma European Organisation for Research and Treatment of Cancer - EORTC Completed No outcome recorded
Phase 2 NCT00002682 Aug 1995 → Oct 2001 lymphoma M.D. Anderson Cancer Center Completed No outcome recorded
Phase 37 trials
Phase 3 NCT07104318 Jul 2026 → Jun 2029 expected Helicobacter pylori infectious disease VA Office of Research and Development Not yet recruiting No outcome recorded
Phase 3 NCT04107194 Jan 2020 → Feb 2021 Helicobacter pylori infectious disease University of Bari Unknown No outcome recorded
Phase 3 NCT02754583 Dec 2015 → Dec 2024 trachoma University of California, San Francisco Completed No outcome recorded
Phase 3 NCT02557932 Sep 2015 → Dec 2018 Helicobacter pylori infectious disease, hereditary gastric cancer National Cancer Center, Korea Completed No outcome recorded
Phase 3 NCT03148366 Feb 2015 → Dec 2019 Helicobacter pylori infectious disease National Taiwan University Hospital Completed No outcome recorded
Phase 3 NCT00712413 Aug → Dec 2008 Helicobacter pylori infectious disease Forest Laboratories Withdrawn No outcome recorded
Phase 3 NCT01098448 Sep 1999 → Dec 2004 periodontitis The Forsyth Institute Completed No outcome recorded
Phase 435 trials
Phase 4 NCT07068607 Apr → Oct 2025 overdue Helicobacter pylori infectious disease, dyspepsia, gastric cancer, gastritis +1 Yongquan Shi Recruiting No outcome recorded
Phase 4 NCT06723197 Dec 2024 → Oct 2025 overdue Helicobacter pylori infectious disease Shandong University Recruiting No outcome recorded
Phase 4 NCT06351891 Apr → Dec 2024 Helicobacter pylori infectious disease Qilu Hospital of Shandong University Unknown No outcome recorded
Phase 4 NCT06695559 Feb 2024 → May 2025 periodontitis Aristotle University Of Thessaloniki Completed No outcome recorded
Phase 4 NCT07312721 Jan → Dec 2024 Helicobacter pylori infectious disease, chronic gastritis, peptic ulcer disease Azfar Farogh Completed No outcome recorded
Phase 4 NCT06168214 Sep 2023 → Nov 2024 overdue Xijing Hospital of Digestive Diseases Recruiting No outcome recorded
Phase 4 NCT05802888 Mar 2023 → Jun 2024 Helicobacter pylori infectious disease Shandong University Unknown No outcome recorded
Phase 4 NCT05586113 Feb → Oct 2023 Helicobacter pylori infectious disease Shandong University Unknown No outcome recorded
Phase 4 NCT06687499 Aug 2022 → Dec 2023 Helicobacter pylori infectious disease National Cheng-Kung University Hospital Completed No outcome recorded
Phase 4 NCT05431075 Jul 2022 → Feb 2024 Helicobacter pylori infectious disease Shandong University Completed No outcome recorded
Phase not applicable25 trials
NCT06943794 Mar 2026 → May 2030 expected gastric cancer Fudan University Not yet recruiting No outcome recorded
NCT07010744 Jul 2025 → Jun 2026 overdue dyspepsia Akil Al Islam Enrolling by invitation No outcome recorded
NCT06977841 Jun 2025 → Mar 2026 Zhongshan Hospital (Xiamen), Fudan University Completed No outcome recorded
NCT04723472 Aug 2023 → Dec 2025 Helicobacter pylori infectious disease Shanghai East Hospital Suspended No outcome recorded
NCT05449028 May 2022 → Dec 2023 Helicobacter pylori infectious disease Unidade Local de Saúde de Coimbra, EPE Unknown No outcome recorded
NCT05126121 Nov 2021 → Jun 2022 Helicobacter pylori infectious disease Xiuli Zuo Unknown No outcome recorded
NCT05133193 Nov 2021 → Jun 2022 Helicobacter pylori infectious disease Shandong University Unknown No outcome recorded
NCT04991584 Aug 2021 → Jun 2022 Helicobacter pylori infectious disease Shandong University Unknown No outcome recorded
NCT04716426 Jan → Mar 2021 COVID-19 University of Nove de Julho Completed No outcome recorded
NCT04730674 Jan → Jun 2020 Zagazig University Completed No outcome recorded
Also used as a comparator or background therapy in 53 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT02099240 Comparator Mar 2014 → Nov 2018 osteomyelitis University of Louisville Terminated No outcome recorded
Phase 11 trial
Phase 1 NCT04066257 Comparator Jan → Feb 2019 HK inno.N Corporation Completed No outcome recorded
Phase 24 trials
Phase 2 NCT07144657 Background Sep 2025 → Dec 2029 expected gastric mucosa-associated lymphoid tissue lymphoma National Taiwan University Hospital Not yet recruiting No outcome recorded
Phase 2 NCT05219929 Comparator Nov 2022 → Jun 2026 post-treatment Lyme disease syndrome Johns Hopkins University Completed No outcome recorded
Phase 2 NCT03656484 Comparator Jan → Dec 2019 chronic periodontitis Concordia Dent Srl Completed No outcome recorded
Phase 2 NCT03632733 Comparator Jan → Oct 2018 Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Unknown No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT00591162 Comparator Oct 1992 → Jun 2008 The University of Texas Medical Branch, Galveston Terminated No outcome recorded
Phase 38 trials
Phase 3 NCT06760065 Comparator Jan 2025 → Dec 2027 expected Helicobacter pylori infectious disease Sixth Affiliated Hospital, Sun Yat-sen University Not yet recruiting No outcome recorded
Phase 3 NCT07487142 Comparator Jun 2024 → Dec 2025 Helicobacter pylori infectious disease Beni-Suef University Completed No outcome recorded
Phase 3 NCT05894954 Background Jul 2023 → Oct 2025 cognitive impairment with or without cerebellar ataxia, dementia Alzheimer's Prevention and Reversal Project, Inc. Completed No outcome recorded
Phase 3 NCT03779074 Comparator Sep 2018 → Dec 2021 Helicobacter pylori infectious disease Kaohsiung Veterans General Hospital. Completed No outcome recorded
Phase 3 NCT02112214 Comparator Jun 2014 → Dec 2029 expected Helicobacter pylori infectious disease, gastric cancer National Cancer Center, Korea Active not recruiting No outcome recorded
Phase 426 trials
Phase 4 NCT07139366 Background Oct 2025 → Sep 2026 expected Helicobacter pylori infectious disease, dyspepsia, gastric cancer, gastritis +1 Yongquan Shi Recruiting No outcome recorded
Phase 4 NCT06561711 Comparator Aug 2024 → Feb 2026 Helicobacter pylori infectious disease Shanghai Jiao Tong University School of Medicine Completed No outcome recorded
Phase 4 NCT06509139 Comparator Jul 2024 → Jul 2032 expected Helicobacter pylori infectious disease National Cheng-Kung University Hospital Enrolling by invitation No outcome recorded
Phase 4 NCT05874570 Comparator Jun 2023 → Oct 2025 overdue Helicobacter pylori infectious disease Shanghai Jiao Tong University School of Medicine Recruiting No outcome recorded
Phase 4 NCT06168084 Comparator Jun 2023 → May 2024 stomach disorder Yongquan Shi Completed No outcome recorded
Phase not applicable12 trials
NCT07533422 Comparator May → Dec 2026 expected Helicobacter pylori infectious disease Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting No outcome recorded
NCT07358130 Comparator Oct 2025 → Nov 2027 expected Helicobacter pylori infectious disease Kaohsiung Medical University Recruiting No outcome recorded
NCT07165444 Comparator Sep 2025 → Feb 2026 overdue Helicobacter pylori infectious disease, proton-pump inhibitor-responsive esophageal eosinophilia Tanta University Recruiting No outcome recorded
NCT06299605 Comparator Nov 2024 → Oct 2025 Helicobacter pylori infectious disease Shandong University Unknown No outcome recorded
NCT04879992 Comparator May 2021 → Oct 2022 Helicobacter pylori infectious disease Shanghai Jiao Tong University School of Medicine Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 129 sources stand behind the page.

FieldValueCited text
Known as Tetracycline “14-day bismuth quadruple therapy (pantoprazole, bismuth subcitrate, tetracycline, and metronidazole for 14 days) or 14-day hybrid therapy (a 7-day dual therapy with...” PMID 28807915 Oct 2017
126

“Bacterial or Viral infection treatment may include: Doxycycline, Minocycline, Nitazoxanide, Hydroxychloroquine, Rifampin, Dapsone, Azithromycin, Tetracycline, Benzathine...” NCT05894954

“A is amoxicillin (1000 mg thrice daily), B is colloidal bismuth subcitrate (120 mg thrice daily), M is metronidazole (500 mg thrice daily), P is a proton pump inhibitor, i.e.,...” NCT06687473

“Fourteen-day esomeprazole, tripotassium dicitrate bismuthate, metronidazole and tetracycline (EBMT) therapy or esomeprazole, moxifloxacin and amoxicillin (MEA) therapy was...” PMID 26452405 Oct 2015

“Placement of CTZ antibiotic paste (chloramphenicol, tetracycline, zinc oxide mixed with eugenol) in the pulp chamber after irrigation with 3% sodium hypochlorite, followed by...” NCT07475364

“amoxicillin 1000mg bid for 10d, clarithromycin 500mg bid for 10d, metronidazole 500mg tid for 10d, tinidazole 500mg tid for 10d, levofloxacin 500mg qd for 10d, furazolidone...” NCT03571230

“Omeprazole 20 mg twice daily, in combination with bismuth subcitrate potassium (40 mg), metronidazole 125 mg and tetracycline 125 mg HCl. All patients must take 6 capsules of...” NCT00712413

“CTZ paste is composed of 62.5 mg of chloramphenicol, 62.5 mg of tetracycline and 125 mg of zinc oxide and manipulated with 0.1ml of eugenol in a sterile glass plate with...” NCT03650036

“Dose of two sensitive antibiotics are listed as follows : amoxicillin 1000mg bid, clarithromycin 500mg bid, tinidazole 500mg tid, levofloxacin 500mg qd, furazolidone 100mg bid,...” NCT03565484

“Multi-drug resistant strains: Esomeprazole 20 mg, Bismuth Potassium Citrate 220 mg, Amoxicillin 1 g, and either Furazolidone 0.1 g (twice daily) or Tetracycline 500 mg (four...” NCT06760065

“oral administration of tegoprazan-based bismuth quadruple therapy(tegoprazan 50 mg b.i.d, bismuth 300 mg q.i.d, metronidazole 500 mg t.i.d, tetracycline 500 mg q.i.d) for 14 days” NCT04674774

“Two antibiotics based on antibiotic sensitivity of H.pylori culture, including amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline and furazolidone.” NCT02894268

“Bismuth 300 mg (4 times a day), lansoprazole 30 mg (twice a day), metronidazole 500 mg (3 times a day), and tetracycline 500 mg (4 times a day) for 10 days” NCT02112214

“rabeprazole 20mg b.i.d + amoxicillin 1000mg b.i.d x 5 days + rabeprazole 20mg b.i.d + clarithromycin 500mg b.i.d + tetracycline 1000mg b.i.d x last 5 days.” NCT01573975

“Patients resistant to both clarithromycin and levofloxacin are assigned to the Tetracycline Group (receiving vonoprazan, amoxicillin, and tetracycline)” NCT07533422

“a capsule containing 3 agents (Pylera®) containing 125mg metronidazole, 140mg bismuth subcitrate potassium, and 125mg tetracycline was made available.” NCT02045251

“Lansoprazole 30mg, 2 times a day + Bismuth 300mg, 4 times a day + Tetracycline 500mg, 4 times a day + Metronidazole 500mg, 3 times a day for 10 days” NCT02557932

“bismuth quadruple therapy: include rabeprazole 20 mg bid, bismuth 120 mg qid, metronidazole 500 mg tid, and tetracycline 500 mg qid, for 14 days” NCT05332444

“bismuth subcitrate 120 mg four times daily, and tetracycline 500 mg four times daily, and metronidazole 250 mg four times daily for 14 days” NCT02547038

“priority antibiotic selection was as follow: Amoxicillin \> Clarithromycin \> Levofloxacin \>Tetracycline \> Furazolidone \> Metronidazole.” NCT02689583

“esomeprazole 40 mg and bismuth 300mg twice daily, tetracycline 500 mg four times daily, metronidazole 500mg three times daily for 10 days” NCT04006340

“rabeprazole 20 mg b.i.d. plus tripotassium dicitrate bismuthate 300 mg, tetracycline 500 mg and metronidazole 250 mg q.i.d. for 10 days” NCT03779074

“Antibiotics are selected from Amoxicillin, Tetracycline, Furazolidone, Levofloxacin, Clarithromycin, Tinidazole, Metronidazole.” NCT05133193

“D1-D10: (esomeprazole 40mg bid + Dibismuth trioxide 120mg qid + metronidazole 500mg tid + tetracycline 500mg qid) for 10 days” NCT03148366

“D1-D10: (esomeprazole 40mg bid + dibismuth trioxide 120mg qid + metronidazole 500mg tid + tetracycline 500mg qid) for 10 days” NCT03156855

“Esomeprazole 40mg bid + bismuth subsalicylate 420mg 6/6h + metronidazole 375mg 6/6h + tetracycline 375mg 6/6h, for 10 days” NCT05449028

“Patients will a 10-day course of bismuth, metronidazole, tetracycline four times daily, and vonoprazan 20 mg twice daily.” NCT07165444

“Bismuth Quadruple therapy consists of Bismuth subcitrate 120mg QDS, Tetracycline 500mg QDS and Metronidazole 500mg TDS.” NCT07010744

“esomeprazole 40 mg bid., tripotassium dicitrate bismuthate 300mg qid, tetracycline 500 mg qid, levofloxacin 500 mg qd.” NCT03779087

Tetracycline 500mg four times Omeprazole 30mg twice Bismuth 600mg twice Metronidazole 500mg three times for 10 days” NCT01938534

“lansoprazole 30mg bid + colloidal bismuth subcitrate 300mg tid + metronidazole 500mg tid + tetracycline 500mg tid” NCT01906879

“powder included dexamethasone, diphenhydramine, tetracycline, metronidazole, nystatin, zinc oxide, and karaya gum” NCT02142543

“esomeprazole 20mg b.d., bismuth subcitrate 120mg q.i.d., tetracycline 250mg q.i.d. and metronidazole 250mg q.i.d.” NCT01306786

“Omeprazole 40 mg BID, Metronidazole 400 mg TID, Tetracycline 500 mg QID, Bismuth subsalicylate for 14 days.” NCT07312721

“Bismuth 524mg QID, Metronidazole 500mg QID, Tetracycline 500MG QID, and Omeprazole 20 mg QID for 14 days.” NCT07104318

“esomeprazole 40 mg b.d., bismuth 120 mg q.d.s., tetracycline 500 mg q.d.s., and levofloxacin 500 mg o.d.” NCT02978157

“Tid group: Amoxicillin 1000mg bid+ Tetracycline 500mg tid+ Bismuth + Esomeprazole 40mg bid” NCT05432115

“Patients received topical Phenytoin 5%+ Tetracycline after necrotic bone debridement .” NCT03269214

“Scheme 5 Amoxicillin 1000 mg, 2 times/d; Tetracycline 500mg, 3 times/d or 4 times/d” NCT04660123

Tetracycline (Huanan Brand, Guangdong Huanan Pharmaceutical Co. LTD.) 500mg qid” NCT05586113

tetracycline 500 mg q.d.s. and levofloxacin 500 mg o.d.) for 14 days” NCT02547025

“and tetracycline (500 mg) four times daily” NCT01967329

Tetracycline® 500 mg qid 7 days (D1-D7)” NCT02373280

“T is tetracycline (500 mg thrice daily)” NCT06687499

Tetracycline® 500 mg qid 7 days (D1-D7)” NCT02373280

tetracycline 500mg three times a day” NCT04713670

“4. Tetracycline: 500mg, 3 times/day” NCT06943794

Tetracycline, 500mg, PO, QID, 1wk” NCT02759029

“3. Tetracycline, 500 mg, bid” NCT01032655

Tetracycline 500mg qid po” NCT04723472

tetracycline 500 mg QID” NCT01643785

tetracycline 500mg qid” NCT01760824

Tetracycline 500mg tid” NCT07068607

tetracycline 500 mg” NCT02547012

“Drug: TetracyclineNCT07139366

“T etracycline” NCT02099240

NCT00889356

NCT05431075

NCT04066257

NCT01763437

NCT04879992

NCT06168084

NCT02175927

NCT04991584

NCT02057926

NCT06168214

NCT03726099

NCT02490839

NCT03658733

NCT07358130

NCT00591162

NCT07487142

NCT06351891

NCT04853875

NCT06723197

NCT05874544

NCT06299605

NCT05802888

NCT05219929

NCT06977841

NCT05345210

NCT00003151

NCT07144657

NCT04678492

NCT03908892

NCT00091247

NCT02754583

NCT05874570

NCT06695559

NCT01293643

NCT05250050

NCT03656484

NCT03139253

NCT03616405

NCT04531059

NCT01880515

NCT05049902

NCT01481844

NCT00002682

NCT04039126

NCT02483715

NCT02988089

NCT01792700

NCT05018923

NCT03634605

NCT04901117

NCT02159976

NCT03708848

NCT04730674

NCT03208426

NCT04527055

NCT03658746

NCT00841854

NCT05850117

NCT01753856

NCT05061732

NCT03609892

NCT06561711

NCT01742429

NCT01668927

NCT03555526

NCT04107194

NCT05126121

NCT03632733

NCT06509139

NCT02359331

NCT01098448

Known as Huanan Brand “Tetracycline (Huanan Brand, Guangdong Huanan Pharmaceutical Co. LTD.) 500mg qid” NCT05586113
Known as tetracycline hydrochloride “each containing 420 mg of bismuth subcitrate potassium, 375 mg of metronidazole and 375 mg of tetracycline hydrochlorideNCT03146325
4

“Drug: tetracycline hydrochlorideNCT00091247

“Drug: Tetracycline HydrochlorideNCT00002682

NCT04716426

NCT01335334

Known as TTC “treatment with tetracycline (TTC) solution” NCT02057926
Route Oral oral tetracycline qid on days 4-10” NCT00003151